Rollout of ShangRing circumcision with active surveillance for adverse events and monitoring for uptake in Kenya.

ABSTRACT:

Introduction

Since 2011, Kenya has been evaluating ShangRing device for use in its voluntary medical male circumcision (VMMC) program according to World Health Organization (WHO) guidelines. Compared to conventional surgical circumcision, the ShangRing procedure is shorter, does not require suturing and gives better cosmetic outcomes. After a pilot evaluation of ShangRing in 2011, Kenya conducted an active surveillance for adverse events associated with its use from 2016-2018 to further assess its safety, uptake and to identify any operational bottlenecks to its widespread use based on data from a larger pool of procedures in routine health care settings.

Methods

From December 2017 to August 2018, HIV-negative VMMC clients aged 13 years or older seeking VMMC at six sites acr

SUBMITTER: Odoyo-June E 

PROVIDER: S-EPMC6762105 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature